Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Daphne Jane Holt, M.D., Ph.D.

Co-Author

This page shows the publications co-authored by Daphne Holt and Oliver Freudenreich.
Connection Strength

0.714
  1. Freudenreich O, Cather C, Holt D. Stimulant misuse in college for "pseudo-attention deficit disorder" during schizophrenia prodrome. Am J Psychiatry. 2006 Nov; 163(11):2019.
    View in: PubMed
    Score: 0.382
  2. Holt DJ, Lakshmanan B, Freudenreich O, Goff DC, Rauch SL, Kuperberg GR. Dysfunction of a cortical midline network during emotional appraisals in schizophrenia. Schizophr Bull. 2011 Jan; 37(1):164-76.
    View in: PubMed
    Score: 0.115
  3. Freudenreich O, Holt DJ, Cather C, Goff DC. The evaluation and management of patients with first-episode schizophrenia: a selective, clinical review of diagnosis, treatment, and prognosis. Harv Rev Psychiatry. 2007 Sep-Oct; 15(5):189-211.
    View in: PubMed
    Score: 0.101
  4. Worthington MA, Petkova E, Freudenreich O, Cather C, Holt D, Bello I, Diminich E, Tang Y, Ardekani BA, Zeng B, Wu R, Fan X, Zhao J, Wang J, Goff DC. Air pollution and hippocampal atrophy in first episode schizophrenia. Schizophr Res. 2020 04; 218:63-69.
    View in: PubMed
    Score: 0.060
  5. Goff DC, Freudenreich O, Cather C, Holt D, Bello I, Diminich E, Tang Y, Ardekani BA, Worthington M, Zeng B, Wu R, Fan X, Li C, Troxel A, Wang J, Zhao J. Citalopram in first episode schizophrenia: The DECIFER trial. Schizophr Res. 2019 06; 208:331-337.
    View in: PubMed
    Score: 0.056
Connection Strength
The connection strength for co-authors is the sum of the scores for each of their shared publications.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.